Search

everythinglearnresearchcommunity

for

Search:↓

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Some drugs for inflammation may cause psoriasis-like hair loss.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

PINCH-1 is crucial for skin cell adhesion and movement, working with EPLIN and ILK.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Lower Paraoxonase 1 levels in alopecia areata patients suggest antioxidant treatment might help.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Mycophenolic acid may help hair grow by activating pathways important for hair growth.

Patched1 helps prevent tumors by controlling cell growth.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Certain medications can cause serious side effects, so it's important to report them.

FOL-026 peptide may help hair growth and cardiovascular health by improving blood flow and cell functions.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

ATP-sensitive potassium channels are important for hair growth.

A PIK3CA mutation in Schwann cells causes severe nerve damage and increased glycolysis, but early treatment can help.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Baricitinib may not always prevent relapse in alopecia areata.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

MIR135b affects wound healing by targeting genes, and PDRN may help heal wounds by altering this pathway.

Targeting the PGI2 pathway may help heal diabetic foot ulcers.